Filing Details

Accession Number:
0001209191-19-060710
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-16 17:17:52
Reporting Period:
2019-12-12
Accepted Time:
2019-12-16 17:17:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426800 Assembly Biosciences Inc. ASMB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1663018 James Richard Colonno C/O Assembly Biosciences, Inc.
11711 N. Meridian St., Suite 310
Carmel IN 46032
Evp & Cso, Virology Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-12 33,061 $7.03 160,882 No 4 M Direct
Common Stock Disposition 2019-12-12 33,061 $25.00 127,821 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-12-12 33,061 $0.00 33,061 $7.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
166,939 2026-01-11 No 4 M Direct
Footnotes
  1. The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Includes 532, 1,000 and 39 shares acquired under the Assembly Biosciences, Inc. 2018 Employee Stock Purchase Plan on November 14, 2018, May 14, 2019 and November 14, 2019, respectively.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.035, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
  4. This option represents a right to purchase 200,000 shares. As of January 5, 2019, 150,000 stock options have vested. The remaining options vest on January 5, 2020.